Clinical Trial: Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458269) titled 'Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes' on March 03.

Brief Summary: The primary objective of this study is to determine the effects of KAI-9531 administered by subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DRUG: KAI-9531

SC Injection

DRUG: Placebo

SC Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Kailera

Published by HT Digital Content Services with permission from Health Daily Digest....